Hypereosinophilia induced by high-dose intratumoral and peritumoral mistletoe application to a patient with pancreatic carcinoma
- PMID: 10976976
- DOI: 10.1089/10755530050120664
Hypereosinophilia induced by high-dose intratumoral and peritumoral mistletoe application to a patient with pancreatic carcinoma
Abstract
A patient with inoperable adenocarcinoma of the pancreas was treated with intraperitumoral and peritumoral injections of a Viscum album L. extract containing 5,700 ng/mL mistletoe lectin, mainly mistletoe lectin 1 (Abnobaviscum Quercus 2) for 5 weeks (1 injection per week). After the third injection (day 22), a marked eosinophilia was observed (1,800 per microliter) that rose to 3,268 per microliter after the fifth injection (day 42). Furthermore, histology performed on day 28 revealed accumulation of eosinophils in ductal lesions and adjacent stroma in addition to the features of ductal adenocarcinoma. In order to investigate whether eosinophilia correlated with immunological features, we analyzed cytokine production of peripheral blood mononuclear cells (PBMC) from this patient after stimulation with antigens known to "unmask" an individual's predisposition for defined immunoreactions, namely purified protein derivative (PPD) as a stimulator of T-helper (TH1)1-cells and tetanus toxoid (TT) as an activator of TH2-cells. PBMC of the patient showed a strong proliferation and production of interleukin (IL)-5 and IL-10 after incubation with TT indicating a type-2 response. Simultaneously, PBMC were induced to proliferate and produce interferon gamma (IFN-gamma) by incubation with PPD suggesting also a type-1 response. These data would readily explain the eosinophilia because eosinophils are effector cells of type-2 reaction but also require type-1 cytokines. Although the overall clinical course of the patient was rapidly progressive, temporary stabilization of the patient's general condition during mistletoe treatment was observed. It is, however, still an open question whether this transient benefit was due to the induction of eosinophilia by a type-2 response.
Conclusion: Before high-dose intratumoral and peritumoral treatment with a Viscum album L. extract containing mistletoe, lectin 1 can be associated with hypereosinophilia and strong production of TH1 as TH2 cytokines as well.
Similar articles
-
[Blood and tissue eosinophilia, mistletoe lectin antibodies and quality of life in a breast cancer patient undergoing intratumoral and subcutaneous mistletoe therapy].Forsch Komplementarmed Klass Naturheilkd. 2002 Jun;9(3):160-7. doi: 10.1159/000064266. Forsch Komplementarmed Klass Naturheilkd. 2002. PMID: 12119512 German.
-
Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract.Eur J Med Res. 1998 Jun 17;3(6):307-14. Eur J Med Res. 1998. PMID: 9620894
-
Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo.Nat Immun. 1998;16(1):34-46. doi: 10.1159/000069428. Nat Immun. 1998. PMID: 9789123
-
Anaphylactic reactions after therapeutic injection of mistletoe (Viscum album L.).Allergol Immunopathol (Madr). 2001 Sep-Oct;29(5):201-3. doi: 10.1016/s0301-0546(01)79056-8. Allergol Immunopathol (Madr). 2001. PMID: 11720654 Review.
-
[Mistletoe therapy from the pharmacologic perspective].Forsch Komplementarmed. 1999 Aug;6(4):186-94. doi: 10.1159/000021248. Forsch Komplementarmed. 1999. PMID: 10529578 Review. German.
Cited by
-
Triterpenoids amplify anti-tumoral effects of mistletoe extracts on murine B16.f10 melanoma in vivo.PLoS One. 2013 Apr 17;8(4):e62168. doi: 10.1371/journal.pone.0062168. Print 2013. PLoS One. 2013. PMID: 23614029 Free PMC article.
-
Abnoba-viscum (mistletoe extract) in metastatic colorectal carcinoma resistant to 5-fluorouracil and leucovorin-based chemotherapy.Med Oncol. 2004;21(3):251-4. doi: 10.1385/MO:21:3:251. Med Oncol. 2004. PMID: 15456952 Clinical Trial.
-
Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract.BMJ. 2006 Dec 23;333(7582):1293-4. doi: 10.1136/bmj.39044.460023.BE. BMJ. 2006. PMID: 17185712 Free PMC article. No abstract available.
-
Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study.Evid Based Complement Alternat Med. 2014;2014:236310. doi: 10.1155/2014/236310. Epub 2014 May 15. Evid Based Complement Alternat Med. 2014. PMID: 24955100 Free PMC article.
-
Long-Term Survival of a Patient with Recurrent Dedifferentiated High-Grade Liposarcoma of the Retroperitoneum Under Adjuvant Treatment with Viscum album L. Extract: A Case Report.Integr Cancer Ther. 2021 Jan-Dec;20:1534735421995258. doi: 10.1177/1534735421995258. Integr Cancer Ther. 2021. PMID: 33618582 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical